Menstrual Pain Medicines Segment Is The Largest Segment Driving The Growth Of Menstrual Cramps Treatment Market.
 |
| Menstrual Cramps Treatment Market |
The global menstrual cramps treatment market is estimated to be valued at US$ 652.3 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Menstrual cramps treatment includes products used to relieve or reduce pain associated with menstrual cramps and is commonly required by women during their menstrual cycle. Various medicines such as ibuprofen, naproxen are widely used for treating menstrual cramps.
Market key trends:
One of the key trends in menstrual cramps treatment market is rising awareness regarding nonsurgical treatment options. Various programs and initiatives by private and government organizations are spreading awareness about conditions such as primary dysmenorrhea and treatment options available to relieve menstrual pain. For instance, International Federation of Gynecology and Obstetrics conducts various awareness programs about conditions affecting women’s health. Another key trend is growing preference for over-the-counter medication owing to easier availability and non-invasive nature. Majority of women utilize readily available medicines to get temporary relief from menstrual cramps instead of opting for complex surgical procedures.
Market key trends:
The Menstrual cramps treatment market is witnessing increasing adoption of non-hormonal pain relief medication as an alternative to hormonal contraceptives and oral analgesics. There is a rise in demand for herbal supplements, transcutaneous electrical nerve stimulation (TENS) therapy devices and heating pads to get relief from cramps in a natural way without any side effects. Moreover, growing awareness about ill effects of prolonged usage of pain killers and availability of various non-drug therapies is boosting the market growth.
SWOT Analysis
Strength: Wide availability of over-the-counter generic drugs and supplements for menstrual pain relief.
Weakness: Risk of side effects and addiction with long term usage of analgesics. Lack of clinical evidence for efficacy of alternative therapies.
Opportunity: Rising preference for herbal and homeopathic supplements creates opportunity for new product launches.
Threats: Intense competition from existing players and entry of local manufacturers with lower prices. Stringent regulatory approvals for new therapies.
Key Takeaways
The Global Menstrual Cramps Treatment Market Size is expected to witness high growth, exhibiting CAGR of 4.4% over the forecast period, due to increasing adoption of herbal supplements and alternative therapies.
North America dominates the global menstrual cramps treatment market share due to growing preference of women towards herbal supplements for pain relief and availability of advanced pain relief devices in the region.
Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other prominent players.
Comments
Post a Comment